In pre-clinical models, BPC 157 has been observed to: Upregulate vascular endothelial growth factor (VEGF) , promoting new blood vessel formation in damaged tissue Modulate nitric oxide (NO) synthesis pathways, influencing vascular tone and healing cascades Interact with the growth hormone receptor system , potentially amplifying downstream tissue repair signaling Demonstrate cytoprotective effects along the gastrointestinal tract its native home territory as a gastric peptide Exhibit apparent neuroprotective properties in rodent models of CNS injury BPC 157 stability in gastric acid unusual for peptides has made it a focus of GI mucosal repair research
If irritation appears, the first step is usually to reduce frequency or pause use, allow the skin to recover, and reintroduce cautiously
The results of an iv drip for skin whitening are not permanent because your body constantly metabolizes antioxidants and is exposed to new environmental stressors
A study to evaluate the efficacy and safety of metformin in vitiligo
Stop using it, and progress will reverse over several months
Current preclinical research on BPC-157 has actually shown protective effects on liver tissue rather than damage, particularly in models of ischemia-reperfusion injury